Delegation of Authorities, 62068 [2011-25851]
Download as PDF
<![CDATA[
62068
Federal Register / Vol. 76, No. 194 / Thursday, October 6, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Delegation of Authorities
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice is hereby given that I have
delegated to the Administrator, Centers
for Medicare & Medicaid Services
(CMS), and the Commissioner, Food and
Drug Administration (FDA), with
authority to re-delegate, the authorities
vested in the Secretary of the
Department of Health and Human
Services under Section 6004 of the
Patient Protection and Affordable Care
Act, Public Law 111–148, which adds
Section 1128H [42 U.S.C. 1320a–7i] to
the Social Security Act.
I hereby delegate to CMS the authority
vested in the Secretary to issue guidance
and take other appropriate actions, to
the extent that Section 1128H [42 U.S.C.
1320a–7i] relates to Titles XVIII
(Medicare), XIX (Medicaid), or XXI
(State Children’s Health Insurance
Program) of the Social Security Act.
I hereby delegate to FDA all other
authority vested in the Secretary under
Section 1128H [42 U.S.C. 1320a–7i].
This shall include, but is not limited to,
issuing guidance and taking other
appropriate action to the extent that
Section 1128H [42 U.S.C. 1320a–7i]
relates to Section 503 of the Federal
Food, Drug, and Cosmetic Act;
identifying the information to be
collected as allowed by Sections
1128H(a)(1)(B) [42 U.S.C. 1320a–
7i(a)(1)(B)] and 1128H(a)(2)(B) [42
U.S.C. 1320a–7i(a)(2)(B)]; and generally,
with respect to the information to be
submitted under Section 1128H(a) [42
U.S.C. 1320a–7i(a)], issuing guidance
and taking other appropriate action to
identify the information to be submitted
and the manner of submission, and
overseeing and making arrangements for
the collection, maintenance, and
availability of such information.
This delegation shall be exercised in
accordance with the Department’s
applicable policies, procedures, and
guidelines.
I hereby affirm and ratify any actions
taken by the Administrator, CMS, the
Commissioner, FDA, or other CMS and
FDA officials, which involve the
exercise of these authorities prior to the
effective date of this delegation.
This delegation of authorities is
effective upon date of signature.
Authority: 44 U.S.C. 3101.
Dated: September 30, 2011.
Kathleen Sebelius,
Secretary of Health and Human Services.
[FR Doc. 2011–25851 Filed 10–5–11; 8:45 am]
BILLING CODE 4150–03–P
VerDate Mar<15>2010
16:07 Oct 05, 2011
Jkt 226001
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
AGENCY:
In accordance with section
10(a) of the Federal Advisory Committee
Act, 5 U.S.C. App. 2, this notice
announces a meeting of the National
Advisory Council for Healthcare
Research and Quality.
DATES: The meeting will be held on
Friday, November 4, 2011, from 8:30
a.m. to 3:30 p.m.
ADDRESSES: The meeting will be held at
the Hubert H. Humphrey Building,
Room 800, 200 Independence Avenue,
SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
Karen Brooks, Coordinator of the
Advisory Council, at the Agency for
Healthcare Research and Quality, 540
Gaither Road, Rockville, Maryland
20850, (301) 427–1801. For press-related
information, please contact Karen
Migdail at (301) 427–1855.
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
October 21, 2011. The agenda, roster,
and minutes are available from Ms.
Bonnie Campbell, Committee
Management Officer, Agency for
Healthcare Research and Quality, 540
Gaither Road, Rockville, Maryland
20850. Ms. Campbell’s phone number is
(301) 427–1554.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Purpose
The National Advisory Council for
Healthcare Research and Quality is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director, Agency for
Healthcare Research and Quality
(AHRQ), on matters related to AHRQ’s
conduct of its mission including
providing guidance on (A) Priorities for
health care research, (B) the field of
health care research including training
needs and information dissemination on
health care quality and (C) the role of
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
the Agency in light of private sector
activity and opportunities for public
private partnerships.
The Council is composed of members
of the public, appointed by the
Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
II. Agenda
On Friday, November 4, there will be
a subcommittee meeting for the National
Healthcare Quality and Disparities
Report scheduled to begin at 7:30 a.m.
The Council meeting will convene at
8:30 a.m., with the call to order by the
Council Chair and approval of previous
Council summary notes. The AHRQ
Director will present her update on
current research, programs, and
initiatives. The final agenda will be
available on the AHRQ Web site at
https://www.ahrq.gov no later than
October 31, 2011.
Dated: September 26, 2011.
Carolyn M. Clancy,
Director.
[FR Doc. 2011–25692 Filed 10–5–11; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–11–11KS]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Daniel Holcomb, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS D–74, Atlanta, GA 30333 or
send an e-mail to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
E:\FR\FM\06OCN1.SGM
06OCN1
]]>Agencies
[Federal Register Volume 76, Number 194 (Thursday, October 6, 2011)]
[Notices]
[Page 62068]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-25851]
[[Page 62068]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Delegation of Authorities
Notice is hereby given that I have delegated to the Administrator,
Centers for Medicare & Medicaid Services (CMS), and the Commissioner,
Food and Drug Administration (FDA), with authority to re-delegate, the
authorities vested in the Secretary of the Department of Health and
Human Services under Section 6004 of the Patient Protection and
Affordable Care Act, Public Law 111-148, which adds Section 1128H [42
U.S.C. 1320a-7i] to the Social Security Act.
I hereby delegate to CMS the authority vested in the Secretary to
issue guidance and take other appropriate actions, to the extent that
Section 1128H [42 U.S.C. 1320a-7i] relates to Titles XVIII (Medicare),
XIX (Medicaid), or XXI (State Children's Health Insurance Program) of
the Social Security Act.
I hereby delegate to FDA all other authority vested in the
Secretary under Section 1128H [42 U.S.C. 1320a-7i]. This shall include,
but is not limited to, issuing guidance and taking other appropriate
action to the extent that Section 1128H [42 U.S.C. 1320a-7i] relates to
Section 503 of the Federal Food, Drug, and Cosmetic Act; identifying
the information to be collected as allowed by Sections 1128H(a)(1)(B)
[42 U.S.C. 1320a-7i(a)(1)(B)] and 1128H(a)(2)(B) [42 U.S.C. 1320a-
7i(a)(2)(B)]; and generally, with respect to the information to be
submitted under Section 1128H(a) [42 U.S.C. 1320a-7i(a)], issuing
guidance and taking other appropriate action to identify the
information to be submitted and the manner of submission, and
overseeing and making arrangements for the collection, maintenance, and
availability of such information.
This delegation shall be exercised in accordance with the
Department's applicable policies, procedures, and guidelines.
I hereby affirm and ratify any actions taken by the Administrator,
CMS, the Commissioner, FDA, or other CMS and FDA officials, which
involve the exercise of these authorities prior to the effective date
of this delegation.
This delegation of authorities is effective upon date of signature.
Authority: 44 U.S.C. 3101.
Dated: September 30, 2011.
Kathleen Sebelius,
Secretary of Health and Human Services.
[FR Doc. 2011-25851 Filed 10-5-11; 8:45 am]
BILLING CODE 4150-03-P
